Prevalence of heart failure with preserved ejection fraction (HFpEF) and symptoms in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The prevalence of HFpEF and related patient-reported functional limitations in MASLD patients with preserved left ventricular...